Sonata Capital Group’s Celgene Corp CELG Stock Holding History

Sonata Capital Group’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,083	Closed	-$245K	–	110
2018 Q2	$245K	Sell	3,083 -1,050	-25%	-$87.2K	0.18%	96
2018 Q1	$369K	Hold	4,133	–	–	0.27%	79
2017 Q4	$431K	Hold	4,133	–	–	0.31%	75
2017 Q3	$603K	Hold	4,133	–	–	0.45%	53
2017 Q2	$537K	Buy	4,133 +100	+2%	+$12.3K	0.4%	55
2017 Q1	$502K	Hold	4,033	–	–	0.38%	56
2016 Q4	$467K	Hold	4,033	–	–	0.36%	60
2016 Q3	$422K	Hold	4,033	–	–	0.34%	66
2016 Q2	$398K	Buy	4,033 +375	+10%	+$38.8K	0.34%	63
2016 Q1	$366K	Buy	3,658 +358	+11%	+$36.9K	0.32%	73
2015 Q4	$395K	Hold	3,300	–	–	0.35%	69
2015 Q3	$357K	Buy	3,300 +650	+25%	+$80.7K	0.33%	71
2015 Q2	$307K	Buy	+2,650	New	+$303K	0.26%	79

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sonata Capital Group's CELG Position: Q3 2018 in Review

Sonata Capital Group sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 3,083 shares — an estimated $245K sold.

Sonata Capital Group first reported a position in CELG in Q2 2015 and held it in 13 quarters. The position peaked at $603K in Q3 2017. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

Sonata Capital Group reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
Sonata Capital Group sold 3,083 Celgene Corp shares in Q3 2018, an estimated $245K.
Sonata Capital Group first reported a position in Celgene Corp in Q2 2015 and held it in 13 quarters.
Sonata Capital Group's Celgene Corp position peaked at $603K in Q3 2017.
1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Sonata Capital Group's 13F filing for Q3 2018, filed 31 Oct 2018.